Opioid addiction kills more people in the United States each year than car accidents. It's not because the people who develop it lack willpower or character. It's because opioids create the most powerful physical dependence of any class of drugs, one that overrides the brain's decision-making systems in ways that aren't addressable through resolve alone.
If you're trying to quit opioids, or helping someone who is, this guide explains what's actually happening in the brain, what recovery looks like, and what the evidence says actually works.
What Opioids Do to the Brain
Opioids, whether heroin, fentanyl, oxycodone, hydrocodone, or morphine, bind to mu-opioid receptors throughout the brain and body. These receptors naturally respond to the brain's own endorphins, regulating pain, mood, and reward. When opioids bind to them, they produce a flood of dopamine in the reward circuit, a signal far more powerful than anything the brain produces naturally.
With repeated use, the brain adapts in two critical ways. First, it reduces its own endorphin production, creating a deficit that makes normal life feel grey and flat without opioids. Second, it downregulates opioid receptors, creating tolerance, the need for more of the drug to achieve the same effect. The person using opioids eventually isn't getting high, they're using to feel normal.
This is why the phrase "just stop" misunderstands the problem. The brain's reward and pain systems have been structurally reorganised around the drug. Recovery is a process of restructuring them back, and that takes time.
The Opioid Withdrawal Timeline
Withdrawal timing depends on the half-life of the specific opioid. Short-acting opioids (heroin, oxycodone, hydrocodone) produce earlier, more intense withdrawal. Longer-acting opioids (methadone, buprenorphine) produce slower, more extended withdrawal.
Short-acting opioids (heroin, oxycodone)
- Hours 6–12: Anxiety, restlessness, drug craving, yawning, runny nose
- Hours 12–36: Peak symptoms, muscle aches, sweating, chills, nausea, vomiting, diarrhoea, insomnia, severe restlessness (the characteristic "restless legs" of opiate withdrawal), goosebumps
- Days 3–5: Symptoms begin to subside. Physical acute withdrawal is largely complete by day 5–7 for most short-acting opioids
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal ends, many people enter a prolonged period of psychological and neurological symptoms that can last months: depression, anxiety, sleep disturbance, difficulty experiencing pleasure (anhedonia), irritability, and intense cravings triggered by people, places, and emotions associated with use. This is PAWS, and it's the period when most relapses occur. Understanding PAWS is critical because it explains why people who successfully detox still relapse weeks or months later. The brain is still healing.
What Actually Works: The Evidence
Medication-Assisted Treatment (MAT)
MAT, using medications like buprenorphine (Suboxone), methadone, or naltrexone (Vivitrol) as part of a recovery plan, is the most evidence-backed approach to opioid use disorder. It consistently outperforms abstinence-only approaches in every outcome that matters: retention in treatment, overdose death, illicit drug use, and HIV transmission.
Buprenorphine (Suboxone) is a partial opioid agonist. It activates opioid receptors partially, preventing withdrawal without producing a significant high. It dramatically reduces cravings and is prescribed by certified physicians. It can be taken at home, which is a major practical advantage.
Methadone is a full opioid agonist used at a controlled dose to eliminate withdrawal. It has the longest track record of any opioid treatment and is highly effective, though it requires daily clinic attendance in most countries.
Naltrexone (Vivitrol) works differently. It blocks opioid receptors entirely, so opioids produce no effect. It's particularly useful for people who have successfully detoxed and want pharmacological support for staying clean. The injectable monthly form (Vivitrol) improves adherence significantly over the daily pill.
The false idea that MAT is "just trading one drug for another" is contradicted by decades of evidence. People on MAT hold jobs, maintain relationships, and rebuild lives. That's the goal of recovery, not simply the absence of a specific molecule.
Behavioural Treatment
MAT works best alongside behavioural intervention. Contingency management, a treatment approach that provides real incentives for clean urine samples, has among the strongest evidence of any psychosocial intervention for opioid use disorder. CBT helps people identify and change the thought patterns and environmental triggers that drive use. Both are additive to medication, not alternatives to it.
Peer Support
Having ongoing connection with people who understand addiction from the inside, SMART Recovery, Narcotics Anonymous, online sober communities, reduces relapse risk significantly. Isolation is one of the most powerful predictors of relapse. Recovery from opioids is not a solo project.
The Overdose Risk After Detox
This point deserves its own section because it saves lives: tolerance drops within days of stopping opioid use. A dose that was tolerated before detox can be lethal afterward. The majority of opioid overdose deaths occur in people who have recently been abstinent, after leaving prison, after completing a detox programme, after a hospitalisation. If you or someone you know has recently detoxed, this is the highest-risk window, and it's why having naloxone (Narcan) available is not optional, it's essential.
If you're in recovery and you're considering using "just once," know that your body no longer has the tolerance it had. Plan accordingly.
What Long-Term Recovery Looks Like
Opioid use disorder is increasingly understood as a chronic condition, like diabetes or hypertension, that requires ongoing management rather than a one-time cure. Most people who achieve lasting recovery do not do so after a single treatment episode. They do so after multiple attempts, accumulating longer and longer periods of stability.
Across those attempts, a few things consistently predict better outcomes: stable housing, employment or structured activity, social support, ongoing treatment engagement (whether medication or counselling), and meaningful connection to something beyond the addiction. The research is consistent: recovery is not an event. It's a process that builds over years.
Tracking daily progress, building accountability, and maintaining structure during the PAWS window, when motivation is low and the brain is still recalibrating, is where the daily work happens. That work looks unglamorous from the outside. But it's what compounds into years of stability.
Frequently Asked Questions
What is the safest way to quit opioids?
The safest way to quit opioids is with medication-assisted treatment (MAT): buprenorphine (Suboxone) or methadone significantly reduces withdrawal severity, cravings, and overdose risk. Starting MAT in an outpatient setting (your primary care doctor can now prescribe buprenorphine without a DEA waiver) is accessible and effective. 'Detox only' without transition to maintenance medication has very high relapse rates. MAT is the evidence-based standard of care.
What medications help you quit opioids?
Three primary options: buprenorphine/naloxone (Suboxone), partial opioid agonist, taken daily, reduces cravings and blocks withdrawal, methadone, full agonist dispensed daily at licensed clinics, older approach but highly effective, naltrexone (Vivitrol), opioid antagonist, blocks opioid effects, used after detox. Buprenorphine is most commonly used for its accessibility, effectiveness, and safety profile. Clonidine helps manage withdrawal symptoms symptomatically but doesn't treat the underlying addiction.
How long does opioid withdrawal last?
Short-acting opioids (heroin, oxycodone, hydrocodone): symptoms begin 8–24 hours after last use, peak at 36–72 hours, acute phase resolves in 4–10 days. Long-acting opioids (methadone): symptoms begin 36–48 hours after last use, peak at 72–96 hours, can persist 2–3 weeks. Post-acute withdrawal syndrome (PAWS), low mood, poor sleep, cravings, energy issues, can persist for months. MAT prevents or significantly reduces both acute and post-acute withdrawal.
What is buprenorphine and how does it help?
Buprenorphine (brand name Suboxone, combined with naloxone) is a partial opioid agonist. It activates opioid receptors enough to prevent withdrawal and cravings without producing significant euphoria at therapeutic doses. It has a 'ceiling effect' (additional doses beyond a threshold don't increase effects), making overdose significantly less likely than full agonists. It's been shown to reduce opioid use, overdose deaths, and criminal activity when taken consistently. Primary care doctors can now prescribe it.
Can you quit opioids cold turkey?
Quitting opioids cold turkey is not dangerous to most otherwise-healthy people (unlike alcohol), but it's extremely uncomfortable and has very high relapse rates. The intense dysphoria and physical suffering of unmanaged withdrawal drives most people back to opioid use. More critically: after a period of abstinence, tolerance resets, if someone relapses after attempting cold turkey, they're at very high overdose risk using their previous dose. MAT is strongly preferred over cold turkey.
What happens to your body when you quit opioids?
Acute phase (days 1–10): autonomic hyperactivity, rapid heart rate, sweating, goosebumps, dilated pupils, runny nose, muscle cramps, nausea, vomiting, diarrhea, insomnia, and intense anxiety and dysphoria. Sub-acute phase (weeks 2–4): physical symptoms resolve but mood remains depressed, sleep disrupted, energy low. Post-acute phase (months): gradual normalization of mood, energy, and sleep as natural opioid receptor function restores.
What does 'maintenance' mean in opioid treatment?
Maintenance means taking buprenorphine or methadone long-term, not as a bridge to abstinence but as ongoing treatment. Research is unambiguous: longer maintenance duration produces significantly better outcomes than short-term use. SAMHSA recommends at least 1–2 years of MAT. Many people do best with indefinite maintenance. The goal is stable functioning and quality of life, not 'being medication-free.' Stopping MAT prematurely is a major cause of relapse and overdose.
What is methadone and how is it different from buprenorphine?
Methadone is a full opioid agonist dispensed at licensed methadone clinics. Differences from buprenorphine: must be taken at a clinic daily (initially, take-home doses earned over time), has higher overdose risk (no ceiling effect), more drug interactions, but may be more effective for some people with severe OUD. Buprenorphine is more accessible (prescribed in offices) and has better safety profile. Both are effective, clinical factors guide which is chosen.
How do I find buprenorphine treatment near me?
SAMHSA treatment locator: findtreatment.gov or 1-800-662-4357. Many primary care physicians can now prescribe buprenorphine without the previous DEA waiver requirement (removed in 2023). Telehealth opioid treatment is available in most states, companies like Bicycle Health, Ophelia, and BrightView provide buprenorphine via video visit. Cost is covered by Medicaid, Medicare, and most private insurance. Access has never been better, the barrier to getting help is lower than it has been.
What is Narcotics Anonymous and does it help?
Narcotics Anonymous (NA) is a 12-step peer support fellowship for people recovering from addiction to opioids and other drugs. Meetings are free and available worldwide, including online. NA emphasizes abstinence (some NA groups are not supportive of MAT, an important consideration if you're on buprenorphine). SMART Recovery is a secular alternative that welcomes people on MAT. Peer support significantly improves outcomes when combined with MAT.
What are the biggest triggers for opioid relapse?
Common relapse triggers: stress (work, relationship, financial), exposure to environments or people associated with past use, pain (especially if opioids were prescribed for pain), depression and untreated mental health conditions, social isolation, overconfidence at the 6-month mark (reducing vigilance), stopping MAT prematurely, and using other substances that lower inhibitions. Knowing your personal triggers, and having specific plans for each, is fundamental to relapse prevention.
What is naloxone and who should carry it?
Naloxone (Narcan) rapidly reverses opioid overdose. It's available without prescription as a nasal spray in all US states. Everyone with opioid use disorder should carry it. Every family member of someone with OUD should have it. In the fentanyl era, multiple doses may be needed. It's free at many health departments, pharmacies, and harm reduction programs. Knowing how to use it (spray into one nostril, call 911, give rescue breaths if trained, repeat in 2–3 minutes if no response) saves lives.
What is the connection between chronic pain and opioid addiction?
Approximately 50% of people with OUD have co-occurring chronic pain. Opioids prescribed for pain can create or worsen dependence, and stopping creates both withdrawal and pain flares, making it very difficult to disentangle. Integrated treatment addressing both pain and OUD simultaneously produces the best outcomes. Buprenorphine has analgesic properties and is increasingly used for both purposes. Non-opioid pain management (physical therapy, nerve blocks, CBT for pain) are important adjuncts.
How does opioid use disorder affect mental health?
OUD is strongly associated with depression, anxiety, PTSD, and other mental health conditions. These often predate addiction (as people self-medicate) and are worsened by opioid use. Untreated co-occurring mental health conditions are a primary driver of relapse. Integrated treatment addressing both OUD and mental health simultaneously produces significantly better outcomes than treating either in isolation. MAT alone doesn't address the mental health component, behavioral treatment is essential.
What are Good Samaritan laws and why do they matter?
Good Samaritan laws provide legal protection to people who call 911 during an overdose, protecting them from prosecution for drug possession. All 50 US states have some form of Good Samaritan protection. Knowing these laws exist matters because fear of legal consequences is a documented reason people don't call 911 during overdoses, costing lives. The specific protections vary by state, know your state's law. In all cases, call 911 first and administer naloxone.
What lifestyle changes help when quitting opioids?
Supporting recovery: regular exercise (significantly reduces depression and improves dopamine function), structured daily routine (reduces unstructured time that becomes trigger-filled), nutrition (opioid use often disrupts eating, rebuilding regular healthy eating matters), sleep hygiene (poor sleep is a major relapse trigger), meaningful activity (work, purpose, connection), and avoiding alcohol and other substances that lower inhibitions. These aren't 'nice extras', they're as important as clinical treatment.
How do I tell my family I'm quitting opioids?
Timing matters: have the conversation when you're sober, calm, and have a concrete plan to share (not just 'I'm going to quit'). Be specific: 'I'm starting buprenorphine treatment with Dr. X next week.' Expect a range of reactions, relief, anger, skepticism, fear. All are understandable. Be clear about what support you need and what isn't helpful (lectures, monitoring, constant questioning). Family therapy or a family counselor can facilitate these conversations. CRAFT training helps families support recovery effectively.
What is fentanyl and why does it make opioid addiction more dangerous?
Illicitly manufactured fentanyl is 50–100x more potent than morphine and is now present in the majority of heroin and many counterfeit pills on the street. A potentially lethal dose is approximately 2 milligrams, invisible to the naked eye. Fentanyl analogs (carfentanil, etc.) are even more potent. Fentanyl test strips detect its presence but not quantity. Every dose of street opioids is potentially lethal. This reality makes naloxone carrying mandatory, not optional.
How long should I be on MAT?
Research consistently shows longer MAT duration = better outcomes. There's no maximum treatment duration, indefinite maintenance is appropriate for many people and is not a failure or crutch. Stopping MAT in the first year is associated with very high relapse and overdose risk. If and when you and your provider agree to taper off MAT, it should be gradual, planned, and tied to robust recovery stability. The decision should be yours and your doctor's, not driven by stigma or external pressure.
What is the overdose risk when quitting opioids and then relapsing?
Extremely high. This is one of the most dangerous scenarios in addiction medicine. When you stop using opioids, tolerance drops rapidly (within days). If you relapse and use your previous dose, your body can no longer process that amount safely, respiratory depression and death result. This is why overdose rates are highest immediately after detox, release from jail, or hospital discharge. MAT prevents this by maintaining tolerance and blocking the reward of relapse. Always have naloxone if you're in early recovery.
Structure for the hard days
Forge gives you a daily streak counter, AI coach check-ins, and a crisis SOS mode for the moments when cravings peak. Built for every addiction, including opioids.
Download Forge, Free TrialSources
- Mattick RP et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014. PMID 24500948
- SAMHSA. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) 63. 2021. samhsa.gov
- Volkow ND et al. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016, 374(4):363-371. PMID 25830321